Efficacy and Safety of Basal-bolus Therapy, Comparing Stepwise Addition of Insulin Aspart Versus Complete Basal-bolus Regimen

NCT01165684 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

401

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 2

Interventions

DRUG: insulin aspart
DRUG: insulin aspart
DRUG: insulin detemir

Sponsor

Novo Nordisk A/S